Triage Medical’s Bio-Clasp
This article was originally published in The Gray Sheet
Executive Summary
Compression locking anchor technology gains 510(k) clearance for use in fixating bone fractures. The technology has greater compressive strength compared to firm's current line of Bone-Lok devices, especially for osteoporotic bone. Triage projects a $700 mil. market potential and it will adapt Bio-Clasp for the spine, hip and hand...
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.